The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Smidt Heart Institute Takotsubo Registry
Cedars-Sinai Medical Center
1,000 participants
Feb 1, 2019
OBSERVATIONAL
Conditions
Summary
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.
Eligibility
Inclusion Criteria2
- Have received a diagnosis of Takotsubo from their physician and consent to enroll
- Submit full medical records needed for Takotsubo adjudication
Exclusion Criteria3
- Younger than 18 years
- Unable to provide informed consent
- Unable to provide the necessary documentation needed for screening purposes
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03910569